Hims and Hers Stops Offering Semaglutide Drugs Following FDA Scrutiny

The company offered a compounded version of the drug that was not approved by the agency.
by is licensed under
ad-image

Get latest news delivered daily!

We will send you breaking news right to your inbox

[ADD FORM IN PSYCODE "follow-us-card"]

Have a tip? Let us know!

ad-image
© 2026 structurefeeds.com, Privacy Policy